Enhancement of radiotherapy efficacy by pleiotropic liposomes encapsulated paclitaxel and perfluorotributylamine

References

• Barker HE, Paget JT, Khan AA, Harrington KJ. (2015). The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 15:409–25.
   PubMed Web of Science ®Google Scholar
• Brown JM, Wilson WR. (2004). Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4:437–47.
   PubMed Web of Science ®Google Scholar
• Castro CI, Briceno JC. (2010). Perfluorocarbon-based oxygen carriers: review of products and trials. Artif Organs 34:622–34.
   PubMed Web of Science ®Google Scholar
• Cui FB, Li RT, Liu Q, et al. (2014). Enhancement of radiotherapy efficacy by docetaxel-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer. Cancer Lett 346:53–62.
   PubMed Web of Science ®Google Scholar
• Davis ME, Chen ZG, Shin DM. (2008). Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7:771–82.
   PubMed Web of Science ®Google Scholar
• Dubey N, Varshney R, Shukla J, et al. (2012). Synthesis and evaluation of biodegradable PCL/PEG nanoparticles for neuroendocrine tumor targeted delivery of somatostatin analog. Drug Deliv 19:132–42.
   PubMed Web of Science ®Google Scholar
• Hiro J, Inoue Y, Toiyama Y, et al. (2010). Possibility of paclitaxel as an alternative radiosensitizer to 5-fluorouracil for colon cancer. Oncol Rep 24:1029–34.
   PubMed Web of Science ®Google Scholar
• Karakashev SV, Reginato MJ. (2015). Progress toward overcoming hypoxia-induced resistance to solid tumor therapy. Cancer Manag Res 7:253–64.
   PubMed Web of Science ®Google Scholar
• Kinner A, Wu W, Staudt C, Iliakis G. (2008). Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res 36:5678–94.
   PubMed Web of Science ®Google Scholar
• Kruh GD, Belinsky MG. (2003). The MRP family of drug efflux pumps. Oncogene 22:7537–52.
   PubMed Web of Science ®Google Scholar
• Lapidus RG, Dang W, Rosen DM, et al. (2004). Anti-tumor effect of combination therapy with intratumoral controlled-release paclitaxel (PACLIMER microspheres) and radiation. Prostate 58:291–8.
   PubMed Web of Science ®Google Scholar
• Lowe KC, Davey MR, Power JB. (1998). Perfluorochemicals: their applications and benefits to cell culture. Trends Biotechnol 16:272–7.
   PubMed Web of Science ®Google Scholar
• Maevsky E, Ivanitsky G, Bogdanova L, et al. (2005). Clinical results of Perftoran application: present and future. Artif Cells Blood Substit Immobil Biotechnol 33:37–46.
   PubMed Web of Science ®Google Scholar
• Mehlen P, Puisieux A. (2006). Metastasis: a question of life or death. Nat Rev Cancer 6:449–58.
   PubMed Web of Science ®Google Scholar
• Murayama C, Kawaguchi AT, Ishikawa K, et al. (2012). Liposome-encapsulated hemoglobin ameliorates tumor hypoxia and enhances radiation therapy to suppress tumor growth in mice. Artif Organs 36:170–7.
   PubMed Web of Science ®Google Scholar
• Notte A, Ninane N, Arnould T, Michiels C. (2013). Hypoxia counteracts taxol-induced apoptosis in MDA-MB-231 breast cancer cells: role of autophagy and JNK activation. Cell Death Dis 4:e638.
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751–60.
   PubMed Web of Science ®Google Scholar
• Ren H, Liu J, Su F, et al. (2017). Relighting photosensitizers by synergistic integration of albumin and perfluorocarbon for enhanced photodynamic therapy. ACS Appl Mater Interfaces 9:3463–73.
   PubMed Web of Science ®Google Scholar
• Riess JG. (2005). Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artif Cells Blood Subst Biotechnol 33:47–63.
   PubMed Web of Science ®Google Scholar
• Safran H, Akerman P, Cioffi W, et al. (1999). Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction. Semin Radiat Oncol 9:53–7.
   PubMed Web of Science ®Google Scholar
• Semenza GL. (2000). HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol (Physiol 88:1474–80.
   PubMed Web of Science ®Google Scholar
• Semenza GL. (2012). Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 33:207–14.
   PubMed Web of Science ®Google Scholar
• Sharts CM, Reese HR, Ginsberg KA, et al. (1978). The solubility of oxygen in aqueous fluorocarbon emulsions. J Fluor Chem 11:637–41.
   Web of Science ®Google Scholar
• Song G, Ji C, Liang C, et al. (2017). TaOx decorated perfluorocarbon nanodroplets as oxygen reservoirs to overcome tumor hypoxia and enhance cancer radiotherapy. Biomaterials 112:257–63.
   PubMed Web of Science ®Google Scholar
• Song X, Feng L, Liang C, et al. (2016). Ultrasound triggered tumor oxygenation with oxygen-shuttle nanoperfluorocarbon to overcome hypoxia-associated resistance in cancer therapies. Nano Lett 16:6145–53.
   PubMed Web of Science ®Google Scholar
• Tang X, Wang G, Shi R, et al. (2016). Enhanced tolerance and antitumor efficacy by docetaxel-loaded albumin nanoparticles. Drug Deliv 23:2686–96.
   PubMed Web of Science ®Google Scholar
• von der Hardt K, Kandler MA, Brenn G, et al. (2004). Comparison of aerosol therapy with different perfluorocarbons in surfactant-depleted animals. Crit Care Med 32:1200–6.
   PubMed Web of Science ®Google Scholar
• Vordermark D, Horsman MR. (2016). Hypoxia as a biomarker and for personalized radiation oncology. Recent Results Cancer Res 198:123–42.
   PubMedGoogle Scholar
• Xu L, Qiu X, Zhang Y, et al. (2016). Liposome encapsulated perfluorohexane enhances radiotherapy in mice without additional oxygen supply. J Transl Med 14:268.
   PubMed Web of Science ®Google Scholar
• Xu S, Tang YY, Yu YX, et al. (2017). Novel composite drug delivery system as a novel radio sensitizer for the local treatment of cervical carcinoma. Drug Deliv 24:1139–47.
   PubMed Web of Science ®Google Scholar
• Young LH, Jaffe CC, Revkin JH, et al. (1990). Metabolic and functional effects of perfluorocarbon distal perfusion during coronary angioplasty. Am J Cardiol 65:986–90.
   PubMed Web of Science ®Google Scholar
• Yu Y, Xu S, You H, et al. (2017). In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma. Drug Deliv 24:75–82.
   PubMed Web of Science ®Google Scholar
• Zhang R, Song X, Liang C, et al. (2017). Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancer. Biomaterials 138:13–21.
   PubMed Web of Science ®Google Scholar
• Zhang W, Li C, Shen C, et al. (2016). Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment. Drug Deliv 23:2575–80.
   PubMed Web of Science ®Google Scholar